RE:RE:RE:RE:RE:RE:Other licensed producers using cloneshipperProduction patients grew 5x faster than the overall patients. I know that we don't have enough data to predict future growth yet, but I'd hardly say that there's any indication that growth is going to slow to zero by next quarter.
As for selling clones to other LPs, I've also pointed out how this can be profitable for the company buying the clones. Each plant can yield $1000 - $2000 worth of dried bud, depending on how well you grew it and what price you sell it for. So if they charge $100 a plant to LPs, that would still be only 5 - 10% of the overall cost.
One plant can even produce up to 1000 grams under the right conditions, which would put my projections on profits for the company who bought the clones even higher.
https://www.ilovegrowingmarijuana.com/marijuana-cannabis-yield-how-much/ At the same time, they save the cost of having a grow room specfically for producing clones and mother plants, as well as the costs of additional employees and equipment. So either way they have to pay to produce clones or pay THC Biomed to produce clones for them.
DiligentSon wrote: With medicinal patients? Yes I do think it will hold up. I also expect that patient growth to drastically lose steam once rec is underway. How many rec users will grow their own? That remains to be seen. I still do not believe you will see other LPs flocking to buy clones from anyone else...I've stated before that I think it's fiscally irresponsible.